Skip to main content Back to Top
Advertisement

11/30/2023

Trimethobenzamide Capsules

Products Affected - Description

    • Tigan oral capsule, Pfizer, 300 mg, bottle, 100 count, NDC 61570-0079-01

Reason for the Shortage

    • Pfizer discontinued oral Tigan in 2021. They expect supplies to be depleted by May 2021.
    • Chartwell launched trimethobenzamide capsules in late-2023.

Available Products

    • Trimethobenzamide oral capsule, Chartwell, 300 mg, bottle, 30 count, NDC 62135-0773-30

Estimated Resupply Dates

    • Chartwell has trimethobenzamide 300 mg capsules available.

Updated

Updated November 30, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 10, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT